To view this email as a web page, click here.
 
FDA reviewing safety of Parkinson’s drug
FDA is re-examining the safety of a breakthrough Parkinson’s disease drug after reports of hundreds of deaths.
Read more
 
First infant epinephrine injector on the market
After FDA approved the first epinephrine injection specifically for infants and toddlers last year, the drug is now on the market.
Read more
 
FDA approves first-of-its-kind diabetes management device
FDA okayed the marketing of a new continuous glucose monitoring system for diabetics—the first to be used as part of an integrated system with other compatible medical devices and electronic interfaces.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.